Antidepressant 99% Vortioxetine Hydrobromide Purity Vortioxetine Hydrobromide Pharmaceutical Vortioxetine Hydrobromide

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Vortioxetine Hydrobromide
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Vortioxetine Hydrobromide
• Name: Vortioxetine Hydrobromide Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antidepressant;Anti-Anxiety
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 960203-27-4
• Mf: C18h23brn2s
• MW: 379.36
• Sample: Avaliable
• Storage: Normal
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

Antidepressant 99% Vortioxetine Hydrobromide Purity Vortioxetine Hydrobromide Pharmaceutical Vortioxetine Hydrobromide

Product Description

Product Details

Product name	Vortioxetine Hydrobromide
Appearance	White powder
CAS NO.	960203-27-4
MF	C18H23BrN2S
MW	379.36

Vortioxetine hydrobromide is a novel bisaryl thioalkylamine antidepressant co-developed by Takeda Japan and Lingbei, Denmark. It is used in the treatment of depression and anxiety disorders. In September 2013, it was awarded the United States. The FDA approved the listing for the treatment of major depressive disorders in adults. In October of the same year, vodisidinetin's marketing authorization application (MAA) received positive opinion from the European Medicines Agency (EMA) Human Medicine Products Committee (CHMP), 2013 In December of this year, the EMA European Commission granted wattacetin to its sales rights throughout the EU. There are four specifications for vortioxetine: 5 mg, 10 mg, 15 mg, and 20 mg.

Valticetine hydrobromide is considered to be a novel multi-model antidepressant drug. In vitro studies have shown that it can antagonize 5-HT3, 5-HT7 and 5-HT1D receptors, activate 5-HT1A receptors, and partially activate 5- HT1B receptors and inhibit 5-HT transport.

Vortioxetine is another antidepressant drug that was developed to replace patent expired drug citalopram.

Application&Function

Valticetine hydrobromide is considered to be a novel multi-model antidepressant drug. In vitro studies have shown that it can antagonize 5-HT3, 5-HT7 and 5-HT1D receptors, activate 5-HT1A receptors, and partially activate 5- HT1B receptors and inhibit 5-HT transport.
 

For the treatment of mild to moderate or severe depression Neurogenic and Reactive Depression Physiotherapy, especially gastrointestinal distress Depression Anxiety Depression in patients with alcohol dependence during withdrawal.

Specification